Gilead Sciences, 10% Owner of Assembly Biosciences ASMB, has filed 10 purchases and 0 sales on the open market. The latest trade was on 05/26.

Gilead Sciences

10% Owner

Company

Assembly Biosciences ASMB

First filing

23/06/28

Trades

26 trades

Buys / sales

10 / 0

12-month net buying

No record

Last trade

05/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Assembly BiosciencesASMB	Open-market buy	25/08/08	25/10/03	2,295,920 sh	In footnote	No stated value	+103.9%
Arcus BiosciencesRCUS	Open-market buy	25/02/18	25/02/20	1,363,636 sh	$11.00	$14,999,996	+4.5%
Assembly BiosciencesASMB	Open-market buy	24/12/19	24/12/23	940,499 sh	$21.37	$20,098,463.63	+74.1%
Xilio TherapeuticsXLO	Open-market buy	24/12/18	24/12/19	1,759,978 sh	$1.04	$1,830,377.12	+24.0%
Assembly BiosciencesASMB	Open-market buy	24/06/17	24/06/20	179,500 sh	In footnote	No stated value	+16.5%
Xilio TherapeuticsXLO	Open-market buy	24/04/02	24/04/03	485,250 sh	$0.76	$368,790	+7.1%
Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/13	910,000 sh	$22.00	$20,020,000	+28.3%
Arcus BiosciencesRCUS	Open-market buy	24/01/29	24/01/31	15,238,095 sh	$21.00	$319,999,995	+102.8%
Arcus BiosciencesRCUS	Open-market buy	23/06/28	23/06/30	1,010,000 sh	$19.26	$19,452,600	+7.3%
Kalaris TherapeuticsKLRS	Open-market buy	23/06/27	23/06/28	2,930,870 sh	$3.75	$10,990,762.5	+21.4%